Subscribe
Home
Issues
Latest Issue
Issue Archive
Special Issues
2022 Midyear Review: Non–Small-Cell Lung Cancer
2022 Oncology Biosimilar Guide to Patient Support Services
2022 Breast Cancer Guide to Patient Support Services
Browse By Topic
Practice Management
Financial Management
Reimbursement
Health Policy
Quality Care
ICD Codes
Survivorship
FDA Approvals, News & Updates
In the News
Guide to Patient Support Services
Index
Introduction
2023 Spotlight: Amgen
Conference Correspondent
ASCO 2022 - Wrap Up
NSCLC IO 2022 - Midyear Review
SABCS 2021 Wrap-Up
Dual IO 2021 Year in Review
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Webinars
Rapid Reactions
In the News
Quick Quiz
Multiple Myeloma Monthly Minutes
Melanoma Monthly Minutes
Press Releases
Women's Health Monthly Minutes
Lung Cancer Monthly Minutes
Gastrointestinal Cancer Monthly Minutes
Issues
2021
December 2021, Vol 11, No 12
December 2021, Vol 11, No 12
Transforming Oncology Drug Pricing with Greater Value in Mind
By
William King
AVBCC Summit Highlights
Oncologic drug pricing is being transformed with greater value in mind. At the 11th Annual Summit of the Association for Value-Based Cancer Care in 2021, a panel led by moderator William McGivney, PhD, Managing Principal, McGivney Global Advisors, Wayne, PA, discussed innovation in drug pricing, how the current rebate system supports higher drug costs, balancing new interventions with profits, and the implications of drug price negotiations being considered in Congress.
Read More ›
Patients in Financial Tug of War Under PBM Alternate Funding Programs
By
Dawn Holcombe, MBA, FACMPE, ACHE
From the Editor
Pharmacy benefit managers (PBMs) have developed a new approach to marketing themselves as stewards of the self-funded employers’ healthcare benefit, and it is having direct negative consequences for patients. Under the alternate funding program, new or costly therapies used to treat serious and chronic conditions, including cancer, are being singled out.
Read More ›
Pharmacist-Driven Intervention Leads to Significant Increase in Biosimilar Adoption
By
Charlie Dawson
Biosimilars
Rapid adoption of FDA-approved biosimilars is feasible, measurable, and scalable—and pharmacists should lead the charge, according to data presented at the 2021 American Society of Clinical Oncology Quality Care Symposium.
Read More ›
Health Plans and Employers Look to Value-Based Contracts to Manage Oncology Costs While Keeping Focus on Patients
By
William King
AVBCC Summit Highlights
At the 11th Annual Summit of the Association for Value-Based Cancer Care in 2021, health plans and employers discussed the utility of value-based contracting for managing oncology care costs while maintaining focus on outcomes of value for patients. Rob O’Brien, Vice President, Specialty, Real Endpoints, Florham Park, NJ, served as moderator for this session.
Read More ›
The Impact of Telehealth on Quality, Access, and Cost in Cancer Care
By
William King
AVBCC Summit Highlights
The use of telehealth in the fee-for-service program surged by more than 4000% during the first 6 months of the COVID-19 pandemic.
Read More ›
Looking Back and Looking Forward
By
Mary K Makarewicz
Practice Management
As 2021 comes to an end, it is vital that practice managers are well-equipped with the skills and knowledge they need as they move forward into 2022.
Read More ›
The mRNA COVID-19 Vaccine Appears Safe and Effective in Patients with Cancer Receiving Active Treatment
By
William King
COVID-19 & Cancer
Vaccination with the mRNA-1273 vaccine (Moderna) appears safe in patients with solid tumors receiving immunotherapy, chemotherapy, or chemoimmunotherapy.
Read More ›
Antibody–Drug Conjugate Shows Promising Activity in Advanced or Metastatic EGFR Mutation–Positive NSCLC
By
Patricia Stewart
Lung Cancer
Patritumab deruxtecan (HER3-DxD), an investigational antibody–drug conjugate targeting the
HER3
growth factor receptor, showed promising activity in patients with locally advanced or metastatic
EGFR
mutation–positive non–small-cell lung cancer (NSCLC) who had received previous
EGFR
tyrosine kinase inhibitor (TKI) therapy, according to interim results from a phase 1 dose-escalation and dose-expansion trial.
Read More ›
Pilot Study Shows Clinical Benefit with Nivolumab in Pediatric Patients with Hypermutant Cancers
By
Charlie Dawson
Pediatric Cancer
The immune checkpoint inhibitor nivolumab (Opdivo) appears to be effective in pediatric patients with hypermutant or ultra-hypermutant cancers, according to results from a pilot study presented during the American Society of Clinical Oncology 2021 annual meeting.
Read More ›
Select Ongoing Trials Currently Enrolling Patients with Colorectal Cancer
Clinical Trials Tracker
The following clinical trials represent a selection of key studies currently recruiting patients with colorectal cancer for inclusion in investigations of new therapies and new regimens of existing treatments for the disease. Each clinical trial description includes the NLM Identifier to be used as a reference with ClinicalTrials.gov. This information can help oncology practice managers and providers direct eligible patients to one of these clinical trials.
Read More ›
View the Latest Issue of OPM
Read Issue
Top Trending Articles
1.
Specialty Carve-Out Models Cost Patients and Employers More Than They Disclose
By
Dawn Holcombe, MBA, FACMPE, ACHE
2.
Best Practices: Education for Patients with Advanced NSCLC Treated with Immune Checkpoint Inhibitors
By
Marianne Davies, DNP, ACNP, AOCNP, FAAN
;
Shawn Perkins, RN, BSN, OCN
3.
Dexamethasone-Sparing Regimen Safe and Effective in Frail Patients with Multiple Myeloma
By
William King
Home
Issues
Latest Issue
Issue Archive
Special Issues
2022 Midyear Review: Non–Small-Cell Lung Cancer
2022 Oncology Biosimilar Guide to Patient Support Services
2022 Breast Cancer Guide to Patient Support Services
Browse By Topic
Practice Management
Financial Management
Reimbursement
Health Policy
Quality Care
ICD Codes
Survivorship
FDA Approvals, News & Updates
In the News
Guide to Patient Support Services
Index
Introduction
2023 Spotlight: Amgen
Conference Correspondent
ASCO 2022 - Wrap Up
NSCLC IO 2022 - Midyear Review
SABCS 2021 Wrap-Up
Dual IO 2021 Year in Review
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Webinars
Rapid Reactions
In the News
Quick Quiz
Multiple Myeloma Monthly Minutes
Melanoma Monthly Minutes
Press Releases
Women's Health Monthly Minutes
Lung Cancer Monthly Minutes
Gastrointestinal Cancer Monthly Minutes